	Mucin-producing cystic hepatobiliary neoplasms: Key diagnostic information for radiologists. Radiologia (Engl Ed) Berbel Rodríguez A, García-Baizán A, Frade-Santos S, Robles Gómez A, Franco PN, Otero-García M. PMID: 41224379 [PubMed - indexed for MEDLINE]
	Exosomal miRNA-720 as a potential diagnostic and prognostic biomarker for hepatocellular carcinoma. Korean J Intern Med Kim JM, Kim HS, Kim JS, Han JW, Lee SK, Nam H, Sung PS, Bae SH, Choi JY, Yoon SK, Jang JW. PMID: 41223874 [PubMed - indexed for MEDLINE]
	A Rare Case of Hepatosplenic Î³Î´ T-Cell Lymphoma with Hemophagocytic Syndrome. Clin Lab Jia W, Xu L. PMID: 41221762 [PubMed - indexed for MEDLINE]
	Concordance of cancer-associated cytokines and mitochondrial DNA deletions in individuals with hepatocellular carcinoma and people living with HIV in Ghana. BMC Gastroenterol Aboagye JO, Ayanful-Torgby R, Zhou L, Wormenor PP, Ganu V, Tachi K, Attoh BNA, Mensah M, Kuuguu T, Mensah SK, Kyei GB, Paintsil E. PMID: 41219858 [PubMed - indexed for MEDLINE]
	Identification of CAF signature genes and construction of CAF-based risk signature in hepatocellular carcinoma by multi-omics analysis. Front Immunol Qian W, Wu K, Shen Z, Ni B, Zheng H, Liu Y, Guo M. PMID: 41208981 [PubMed - indexed for MEDLINE]
	FCGR2A defines prognostic immune subtypes and drives tumor progression in hepatocellular carcinoma. Front Immunol Zhong D, Liang Y, Yan H, Chen X, Chen Y, Ma S, Su Y, Wang F, Chen X, Yang Q, Leng Z, Wang M, Huang X. PMID: 41208969 [PubMed - indexed for MEDLINE]
	Hepatic arterial infusion chemotherapy combined with lenvatinib and toripalimab for large hepatocellular carcinoma (> 10 cm) with major portal vein tumor thrombosis: a multicenter propensity score matching analysis. Front Immunol Li Y, Wang D, Zhang F, Zheng X, Song Y, Ran Y, Cai X. PMID: 41208968 [PubMed - indexed for MEDLINE]
	The PI3K/Akt/mTOR Pathway: Immuno-Metabolic Orchestration in IR/MASH-Associated Hepatocellular Carcinoma. Int J Biol Sci Zhao J, Zhang Y, Wei Z, Li K, Sun L, Li D, Wang Y. PMID: 41208895 [PubMed - indexed for MEDLINE]
	Prognostic evaluation of glycolysis markers in hepatocellular carcinoma: insights from meta-analysis and multi-omics approaches. BMC Med Genomics Li G, Li Y, Zhou J, Tang S, Guo H, Lin J. PMID: 41206438 [PubMed - indexed for MEDLINE]
	Causal relationship between serum bilirubin, cholelithiasis and hepatobiliary and pancreatic malignancy: A bidirectional and 2-sample Mendelian randomization study. Medicine (Baltimore) Luo T, Wang S, Yang S, Zhao X, Su A, Qin J, Liu Y, Zhou W. PMID: 41204473 [PubMed - indexed for MEDLINE]
	A fixation-compatible protocol for intracellular and surface marker-based detection of circulating tumor cells in hepatocellular carcinoma. Sci Rep Zhu B, Yoshida K, Luu H, Zhang H, Passero JV, Liu K, Lin SY, Su YH, Song H, Hamilton JP, Zhu Q, Anders RA, Kim AK. PMID: 41203725 [PubMed - indexed for MEDLINE]
	Recent Advancements in Known and Emerging Risk Factors of Hepatocellular Carcinoma. Cancer Med Hussain MM, Feng B, Wang JM, Zhai AQ, Li FY, Hu HJ. PMID: 41201177 [PubMed - indexed for MEDLINE]
	Nivolumab in gastric cancer with liver metastasis complicated by immune-mediated hepatitis: a case report and FAERS database analysis. Front Immunol Zhang YL, Zhao JL, Qu KJ, Jiao ZL, Chen YR, Zhou J, Li JL, Li JW. PMID: 41200202 [PubMed - indexed for MEDLINE]
	Identification of immunogenic cell death signature genes in hepatocellular carcinoma: from single-cell transcriptomics to in vitro mechanistic validation and comprehensive prognostic modeling with hundreds of machine learning algorithms. Front Immunol Liu H, Sun Z, Wang X, Zhou B, Cha L. PMID: 41200185 [PubMed - indexed for MEDLINE]
	Prognostic analysis of different postoperative adjuvant therapies for patients with hepatocellular carcinoma after radical resection with high-risk recurrence factors: a multicenter real-world retrospective study. Front Immunol Zhao Z, Xiao Y, Su CG, Zhao H, Li J, Liu J. PMID: 41200181 [PubMed - indexed for MEDLINE]
	Radiological characteristics for guiding intra-arterial therapy in intermediate-stage hepatocellular carcinoma. BMC Med An C, Zheng G, Zhou J, Wei R, Wu P, Zuo M. PMID: 41199230 [PubMed - indexed for MEDLINE]
	Study on the Mechanism of CCN2 Promoting Sorafenib Resistance in HCC and Its Combined Intervention Strategy. Front Biosci (Landmark Ed) Cui L, Liu J, Lv Y, Chen B, Liu K, Bu Y. PMID: 41198556 [PubMed - indexed for MEDLINE]
	Artificial Intelligence in the Evolution of Interventional Therapy for Liver Cancer: Navigating the Tumor Microenvironment. Front Biosci (Landmark Ed) Xiu Z, Zeng W, Guo J, Tu G, Chen X, Sheng J, Chen H. PMID: 41198535 [PubMed - indexed for MEDLINE]
	Benefit and prognosis prediction of radiation therapy in colorectal cancer liver metastases: a retrospective, population-based, propensity score-matched study. BMJ Open Wei T, Pan Z, Feng X, Long Y. PMID: 41198210 [PubMed - indexed for MEDLINE]
	Hepatic arterial infusion is effective in patients with unresectable colorectal liver metastases refractory to standard systemic chemotherapy: A retrospective cohort study. PLoS One Ishii M, Itano O, Iwamoto H, Takami Y, Okada N, Inoue T, Itano S. PMID: 41196875 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 73520

Page 1 of 3676



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy